Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data-Reference-Cited by-同舟云学术

Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data

Published:2018-05 Issue: Volume:Volume 12 Page:869-878
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Wolf Douglas C,Jaganathan Srihari,Burudpakdee Chakkarin,Seetasith Arpamas,Low Robert,Lee Edward,Gucky Jay,Yassine Mohamed,Schwartz David A

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW;North American Actuarial Journal;2022-09-09

2. Payer-Addressable Burden of Crohn's Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW;N AM ACTUAR J;2022

3. Impact of Home Care Services on Patient and Economic Outcomes: A Targeted Review;Home Health Care Management & Practice;2021-08-31

4. Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review;Immunotherapy;2021-04

5. Patients’ perspectives on medication for inflammatory bowel disease: a mixed-method systematic review;European Journal of Gastroenterology & Hepatology;2020-08-07